CITADEL ADVISORS LLC - 31 Mar 2025 SCHEDULE 13G/A Report for VYNE Therapeutics Inc. Common Stock, par value $0.0001 (VYNE)

Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Security
VYNE Therapeutics Inc. Common Stock, par value $0.0001
Symbol
VYNE
Shares outstanding
15,282,347 shares
Disclosed Ownership
1,100,329 shares
Ownership
7.2%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 17:28:40 UTC
Date of event
31 Mar 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 6.8% 1,040,070 0 1,040,070 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 6.8% 1,040,070 0 1,040,070 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 6.8% 1,040,070 0 1,040,070 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0.4% 58,260 0 58,260 /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities Group LP 0.4% 60,259 0 60,259 /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities GP LLC 0.4% 60,259 0 60,259 /s/ Guy Miller Guy Miller, Authorized Signatory
Kenneth Griffin 7.2% 1,100,329 0 1,100,329 /s/ Seth Levy Seth Levy, attorney-in-fact*